Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients. [PDF]
Pak J Med Sci, 2018 Mohamad WMW +3 more
europepmc +1 more source
Elevated anti-cyclic citrullinated peptide antibody titer is associated with increased risk for interstitial lung disease. [PDF]
Clin Rheumatol, 2019 Correia CS +3 more
europepmc +1 more source
Anti-cyclic Citrullinated Peptide Antibodies in Early Rheumatoid Arthritis
Japanese Journal of Rheumatism and Joint Surgery, 2006 openaire +1 more source
The Role of Anti-Cyclic Citrullinated Peptide Antibody in Periodontal Disease
International Journal of Immunopathology and Pharmacology, 2010 The anti-Cyclic Citrullinated Peptide Antibodies (anti-CCP) are produced locally in the inflamed synovium of Rheumatoid arthritis (RA) patients, suggesting that citrullinated proteins are located in the inflamed synovium. In scientific literature were find periodontal bacterial DNA in serum and synovial fluid of RA with PD patients.
Andrea Ballini +2 more
exaly +8 more sources
Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis
Journal of Dermatological Science, 2009 Anti-cyclic citrullinated peptide antibodies (anti-CCP) are reported to be found in 5-13% of patients with psoriatic arthritis (PsA). However, whether anti-CCP-positive PsA patients and rheumatoid arthritis (RA) patients have a similar pathophysiological background still remains uncertain.To determine the prevalence of anti-CCP antibodies in patients ...
Yayoi Tada
exaly +4 more sources
Related searches:
Anti-cyclic citrullinated peptide antibodies in scleroderma patients
Clinical Rheumatology, 2012Anti-CCP (cyclic citrullinated peptide) is considered the most useful laboratory tool in the diagnosis of rheumatoid arthritis (RA). Some authors have also found this autoantibody in patients with scleroderma (SSc). The study aimed to investigate the prevalence of anti-CCP antibodies in SSc patients from Southern Brazil and their association with ...
M, Polimeni +3 more
openaire +2 more sources
Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis
Future Rheumatology, 2006Rheumatoid arthritis (RA) is a chronic inflammatory disorder characterized by the destruction of multiple joints along with multiple organ involvement. The etiology of RA is still unknown. Various autoantigens have been proposed as targets of pathogenic T and B cells in RA, although none of their precise mechanisms or significance has been confirmed ...
Ryo Yamada +2 more
openaire +1 more source
Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
The Indian Journal of Pediatrics, 2010Prevalence and clinical significance of anti-cyclic citrullinated peptide (CCP) antibodies in Indian patients with juvenile idiopathic arthritis (JIA).Anti-CCP antibodies were determined by enzyme-linked immunosorbent assay (ELISA) in 78 patients with JIA which included all 3 major subtypes of the disease: pauciarticular, polyarticular afld systemic ...
R, Gupta +5 more
openaire +2 more sources
Anti-cyclic citrullinated peptide (anti-CCP) antibodies with brucellosis
Rheumatology International, 2013Anti-cyclic citrullinated peptide (anti-CCP) was positive in 11.5 % and rheumatoid factor was positive in 8.8 % of the patients with Brucella. After a comparative evaluation, we have found out that there was not a statistical significance concerning the anti-CCP levels between the patients with brucellosis and healthy control.
Pehlivan, YAVUZ +8 more
openaire +3 more sources